Contact
Please use this form to send email to PR contact of this press release:
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
TO:
Please use this form to send email to PR contact of this press release:
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
TO: